Navigation Links
First corneal transplant with pre-loaded donor tissue performed at Mass. Eye and Ear
Date:5/7/2013

Boston (May 7, 2013) The first successful cornea transplant with donor endothelial tissue preloaded by an eye bank has been performed at Massachusetts Eye and Ear in Boston, Mass. Roberto Pineda II, M.D., Director of the Refractive Surgery Service at Mass. Eye and Ear, and an Associate Professor of Ophthalmology at Harvard Medical School, recently performed the groundbreaking transplant.

Dr. Pineda performed the surgery utilizing donor endothelial tissue that was prepared and pre-loaded into EndoGlide (Angiotech Pharmaceuticals, Inc.) cartridges at the Lions Eye Institute for Transplant & Research (LEITR) in Tampa, FL.

According to Dr. Pineda, using preloaded donor tissue may minimize potential damage to the endothelial cells and, thus, may lead to better outcomes for the patient.

"Reducing any variables that could interfere with a patient's ability to successfully regain sight after surgery is significant," said Dr. Pineda. "The ultimate goal is to improve the quality of life for our patients," Dr. Pineda said.

A world-leading cornea expert and refractive surgeon at Mass. Eye and Ear, Dr. Pineda has collaborated with LEITR and Angiotech/Sharpoint for the last seven months to help develop the innovative procedure.

"I am pleased that - with Dr. Pineda leading these efforts - Mass. Eye and Ear is at the forefront of implementing an innovative technology that could greatly improve the quality of surgical outcomes for patients facing partial or complete vision loss," said Joan W. Miller, M.D., FARVO, Chief and Chair of Ophthalmology at Mass. Eye and Ear and Harvard Medical School.

Last year, LEITR reported that eye banks are able to safely prepare and load corneal tissue into the EndoGlide cartridges. In a pre-clinical study presented at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, corneal buttons pre-loaded by LEITR sustained an average of 9.07% endothelial cell damage, compared to 36.2% endothelial cell damage in control group tissue that was loaded into the insertion system on site. The difference in endothelial damage between the preloaded and control buttons was statistically significant (P = 0.004).


'/>"/>

Contact: Vannessa Carrington
vannessa_carrington@meei.harvard.du
617-573-3341
Massachusetts Eye and Ear Infirmary
Source:Eurekalert

Related medicine news :

1. McAdams DeMarco Awarded $100,000 as First Arthritis-Aging Collaborative Researcher
2. DocVerify and Wufoo Release First One Click Electronic Signature Web Form Add-On
3. Power Up For Profits! Client Releases First Book at the Age of 71
4. The Discovery House Hosts First Alumni Meeting
5. NFL Kicker Billy Cundiff Launches Kicking For The Dream to Celebrate First World Ovarian Cancer Day, May 08, 2013
6. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Scheduling of First Bellwether Trial in New Jersey C.R. Bard Pelvic Mesh Litigation
7. Health First and Palm Bay Police Department Receive National Recognition for Innovative Telemedicine Project to Help Patients Before they Get to the Hospital
8. Actos Lawyers at Bernstein Liebhard LLP Comment on California Judge’s Decision to Set Aside Verdict in Nation’s First Actos Bladder Cancer Trial
9. First Choice Emergency Room Partners with 99.5 The Wolf to Giveaway Kenny Chesney Concert Tickets
10. Schuylkill Medical Associates Announces Partnership with Integrity First Consulting
11. The Republic of Tea Introduces 2013 First Flush Darjeeling Full-Leaf Organic, Rainforest Alliance Certified™ Tea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: